The Challenges of Using Ki67 as a Tool in Breast Cancer
Torsten O. Nielsen, MD, PhD, FRCPC, a professor of pathology at the University of British Columbia, discusses the difficulties when using Ki67 to measure proliferation in breast cancer.
The Difference Between the PAM50 Assay and Other Molecular Tests
Torsten O. Nielsen discusses the differences between the PAM50 assay and other approved molecular tests for patients with breast cancer.
The Clinical Utility of Ki67 in Breast Cancer
Torsten O. Nielsen, MD, PhD, FRCPC, professor, pathology, University of British Columbia, discusses Ki67 in breast cancer.